Raymond James & Associates »

Axonics Modulation Technolog shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Axonics Modulation Technolog (AXNX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Axonics Modulation Technolog

Tip: Access up to 7 years of quarterly data

All positions including Axonics Modulation Technolog held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axonics Modulation Technolog by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2023-06-30 $431k 8.5k 50.47
2023-03-31 $618k 11k 54.56
2022-12-31 $1.2M 19k 62.53
2022-09-30 $740k 11k 70.40
2022-06-30 $208k 3.7k 56.69
2021-12-31 $322k 5.8k 55.93
2021-09-30 $314k 4.8k 65.01
2021-06-30 $482k 7.6k 63.47
2019-12-31 $243k 8.8k 27.68

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Home Depot (HD)
UnitedHealth (UNH)

View all positions for Raymond James & Associates